Plavix boosts BMS first quarter figures
April 30, 2010Sales and Marketing BMS, Plavix
Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …
Merck separates president role, appoints Kenneth Frazier
April 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing
Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Victoza claims head-to-head victory over Januvia
April 29, 2010Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza
Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …
Investors get green light to continue Merck lawsuit
April 29, 2010Merck, Vioxx
Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …
CME Spotlight: De-coding the letter of the law
April 29, 2010Medical Communications CME, CME Spotlight
Legal systems can raise interesting philosophical points sometimes.At the time of writing, the UK is in the throws of a …
Doctors.net.uk reports record year for online interaction with doctors
April 29, 2010Medical Communications CME, doctors.net, social networking
Online doctors’ community Doctors.net.uk says it saw record levels of doctor engagement in 2009, with 25 million unique web sessions during …
US pharma execs join Algeta board
April 29, 2010Research and Development Algeta, appointment, research and development
Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …
RNA Interference using nanoparticles hits target in human patients
April 29, 2010Research and Development SiRNA, nanoparticles, rnai
US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …
Asia and emerging markets boost GSK results
April 28, 2010Sales and Marketing GSK
Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …
Merck bounces back
April 28, 2010Sales and Marketing Merck KGaA
Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …
Obituary – Tony Forbes-Leith
April 28, 2010Business Services appointment, business services, rsa
RSA director Tony Forbes-Leith passed away last month after a long and serious illness. He officially joined the company in …
AstraZeneca settles Seroquel marketing charges
April 28, 2010Sales and Marketing Seroquel
AstraZeneca has agreed to pay $520 million to settle US federal investigations into the marketing of its antipsychotic blockbuster Seroquel. …
Amgen promotes Robert Bradway to president
April 28, 2010Manufacturing and Production, Sales and Marketing Amgen, appointment, manufacturing and production, sales and marketing
Robert Bradway has been appointed president and chief operating officer at US biotech Amgen. Bradway, currently executive VP and chief …
GE Healthcare and Nycomed in Russian joint venture
April 27, 2010Sales and Marketing GE Healthcare, Nycomed
GE Healthcare and Nycomed have formed a joint venture to market and distribute GE Healthcare’s medical diagnostic contrast agents in …
Crestor gains prevention licence in Europe
April 27, 2010Sales and Marketing AstraZeneca, Crestor, statin
AstraZeneca’s statin treatment Crestor has been approved in the European Union for the prevention of major cardiovascular events in patients …
Turn your people into your competitive advantage
April 27, 2010Business Services careers voice, rsa, talking careers
Nick Stephens, chief executive of RSA, outlines and analyses the major HR and people management issues global life sciences executives’ …
Dr Pia Garguilo and Richard Watts join Qiagen
April 27, 2010Sales and Marketing Qiagen, appointment, sales and marketing
Netherlands-based diagnostics company Qiagen has made two appointments to its new pharma business development team. Dr Pia Gargiulo joins as …
Charles River to buy WuXi for $1.6bn
April 27, 2010Research and Development Charles River, Charles River Laboratories, WuXi, contract research
Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
Synovate appoints Manfred Eberlein
April 26, 2010Sales and Marketing appointment, sales and marketing, synovate
Pharma research company Synovate Healthcare has appointed Manfred Eberlein to head up its operations in Western Europe. In his new …
Digital Pharma: UK election check-up
April 26, 2010Medical Communications NHS, digi game, election, general election
A new lighthearted game from The Kings Fund aims to educate players on the three main political parties’ health and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
